logo transparent gif
top_white_spacer
Home Latest Forum Topics MyCorner - Personal Stocks Porfolio Stock Lists Forex Investor Insights Investment News Investor Research & Links Dynamic Stock Charting FREE Registration About Us top spacer top spacer
 User Password Auto-Login
Enter Stock
 
righttip
branding

Return

TJ DaRenTang USD

T14

2.13

No Change

GroupCash
CashUS Dollar

 

TRADING INFO


Open
2.23
Buy
-
Sell
-
High
2.23
Low
2.13
Previous Close
2.13
Volume(K)
116.7
Buy Volume(K)
3.7
Sell Volume(K)
1.5

KEY STOCK INFOUpdated: 31 Oct 2024


PE Ratio (FY)
3.731173610808477
Dividend Yield % (FY)
26.776664005704166
Price to Book Ratio
0.589250493096647
Market Cap ($million)
3681.57512
Enterprise Value ($million)
1835.6921200000002
52 Weeks High
2.66
52 Weeks Low
1.66
RSI
28.46 ( Oversold )
Williams %R
-100.0 ( Oversold )

 

COMPANY INFORMATION Updated: 23 Nov 2024 Financial Info by


SIC
MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS
Address
NO.17 BAIDI ROAD NANKAI DISTRICT TIANJIN 300193
Phone
(86) 022 2702 0926
Fax
(86) 022 2702 0892
Profile
The Company is mainly engaged in the Chinese herbal medicine, Chinese medicine, Chinese herbal medicine, western medicine, chemical medicine manufacturing, chemical medicine, medical, nutrition and health care products, chemical processing, manufacturing, wholesale and retail; traditional Chinese medicine processing, health supplies, fitness equipment, life and environmental health disinfection supplies, drugs, daily necessities, clothing and skin care products, footwear, household appliances, daily necessities, tobacco wholesale and retail; warehousing, advertising, technology development and transfer, economic information consulting services, such as rental housing.

 

FINANICALS INFORMATION All values in $millions


Financial Year
2021-12-31
2022-12-31
2023-12-31
Currency
CNY
CNY
CNY
KEY RATIOS
FY 2021
FY 2022
FY 2023

Operating Margin(%)
12.826
12.146
13.919
Return on Equity Capital(%)
12.342
13.192
14.953
Net Profit Margin(%)
11.264
10.568
12.141
Current Ratio
2.64
2.174
2.027
Debt to Capital at Book
0.075
0.093
0.086
INCOME STATEMENT
FY 2021
FY 2022
FY 2023

EBITDA
717.14
859.06
1009.052
EBIT
613.689
666.195
771.632
Net Profit
769.145
861.794
986.707
Ordinary Dividend
-386.722
-866.256
-985.803
BALANCE SHEET
FY 2021
FY 2022
FY 2023

Intangibles
202.908
376.823
396.736
Fixed Assets
1483.273
1461.592
1434.741
Long Term Investments
740.741
801.465
882.674
Stock/Inventories
1525.089
1429.453
1566.518
Cash
2283.181
2711.533
1997.386
Current Liabilities
2433.902
3333.435
3232.922
Long Term Debt
3.949
155.249
276.574
Provisions
12.445
10.091
8.149
Minorities
0.0
0.0
0.0
Total Shareholder Equity
6513.829
6551.953
6645.237
PER SHARE INFO
FY 2021
FY 2022
FY 2023

EBITDA per share
0.464
0.555
0.655
EBIT per share
0.564
0.634
0.711
Profit Per Share
0.497
0.557
0.641
Book Value Per Share
4.079
3.992
4.056

 

 


Intraday Chart




ShareJunction Version: 27 Nov 2020 ver- All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright © SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux.